Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2000 R33 PAR-99-100 LAM, KIT S UNIVERSITY OF CALIFORNIA DAVIS LIGANDS FOR ALTERED PHOSPHOPROTEINS IN CANCER Complete
2002 R42 PAR-99-101 SWENBERG, JAMES A ENO RIVER LABS, LLC ULTRASENSITIVE METHODS FOR HUMAN BIOMARKER QUANTITATION Complete
2006 R21 RFA-CA-06-002 TSOURKAS, ANDREW UNIVERSITY OF PENNSYLVANIA NOVEL PROBE FOR QUANTITATIVE IMAGING OF GENE EXPRESSION Complete
2008 R44 RFA-CA-07-041 LEE, PHILIP J CELLASIC CORPORATION MICROFLUIDIC PLATFORM FOR CANCER CELL CULTURE AND ANALYSIS Complete
2012 R21 RFA-CA-12-002 GRZYBOWSKI, BARTOSZ ANDRZEJ NORTHWESTERN UNIVERSITY MICROSYSTEMS FOR TARGETING LEVY WALKS IN METASTATIC CANCER CELLS Complete
2015 R43 PAR-13-327 ORBAI, LUCIAN CELL DATA SCIENCES, INC. RESCUING NUCLEIC ACIDS FROM FORMALIN DAMAGE IN CANCER SPECIMENS Complete
2019 R21 RFA-CA-18-002 ANGEL, PEGGY M MEDICAL UNIVERSITY OF SOUTH CAROLINA Enzymatic Tools for 2D Tissue Localized and Deeper Proteomic Sequencing of Cancer Stromal Proteins Complete
2000 R21 PAR-98-067 ENGELWARD, BEVIN P. MASSACHUSETTS INSTITUTE OF TECHNOLOGY FLUORESCENCE DETECTION OF GENETIC INSTABILITY IN MICE Complete
2002 R21 PAR-99-100 FUTSCHER, BERNARD W UNIVERSITY OF ARIZONA MICROARRAY TECHNOLOGY TO PROFILE CPG ISLAND METHYLATION Complete
2005 R21 RFA-CA-05-003 HAAB, BRIAN B. VAN ANDEL RESEARCH INSTITUTE LONGITUDINAL CANCER-SPECIFIC SERUM PROTEIN SIGNATURES Complete
2008 R21 RFA-CA-07-035 RABINOWITZ, JOSHUA D PRINCETON UNIVERSITY MASS SPECTROMETRY METHODS FOR PROBING METABOLIC DYNAMICS IN NORMAL & CANCER CELLS Complete
2011 R21 RFA-CA-10-005 LAI, JONATHAN ALBERT EINSTEIN COLLEGE OF MEDICINE METHODS TO IDENTIFY HIGH-AFFINITY ANTIBODIES THAT TARGET TUMOR-ASSOCIATED GLYCANS Complete
2015 R21 RFA-CA-14-003 WELSH, JOHN T VACCINE RESEARCH INSTITUTE OF SAN DIEGO A MOLECULAR METHOD TO DETERMINE ISOFORM FREQUENCIES IN RNA-SEQ Complete
2018 R33 RFA-CA-17-011 CIMA, MICHAEL J MASSACHUSETTS INSTITUTE OF TECHNOLOGY Advanced development and validation of microdevices for high-throughput in situ drug sensitivity testing in tumors Complete
1999 R33 PAR-98-067 YATES, JOHN ROBERT UNIVERSITY OF WASHINGTON DIRECT MS ANALYSIS OF COMPLEX PROTEIN MIXTURES Complete
2001 R33 PAR-99-102 GALE, JAMES M UNIVERSITY OF NEW MEXICO MOLECULAR STAGING OF HUMAN SQUAMOUS CELL SKIN CANCER Complete
2004 R33 PAR-01-106 VIDAL, MARC DANA-FARBER CANCER INSTITUTE INTEGRATED INTERACTOME MAPPING Complete
2007 R33 RFA-CA-07-001 MILOSAVLJEVIC, ALEKSANDAR BAYLOR COLLEGE OF MEDICINE MULTIPLEXED METHODS FOR THE STUDY OF CHROMOSOMAL ABERRATIONS IN CANCER Complete
2010 R21 RFA-CA-09-008 CHIU, DANIEL T UNIVERSITY OF WASHINGTON HIGH SENSITIVITY DETECTION AND ISOLATION OF CIRCULATING TUMOR CELLS Complete
2014 R21 RFA-CA-13-003 SEIBEL, ERIC J UNIVERSITY OF WASHINGTON NEEDLE BIOPSY PRESERVATION AND PREPARATION FOR RAPID 3D PATHOLOGY OF PANCREAS Complete
2017 R33 RFA-CA-16-002 KELLEY, SHANA O UNIVERSITY OF TORONTO Development and validation of nanoparticle-mediated microfluidic profiling approach for rare cell analysis Complete
2001 R21 PAR-99-102 PARKOS, CHARLES A EMORY UNIVERSITY PHAGE DISPLAY AND PROSTATE NEOPLASIA PROGRESSION Complete
2003 R33 PAR-01-104 ARAP, WADIH UNIVERSITY OF TEXAS MD ANDERSON CAN CTR STEM CELL-BRAIN TUMOR INTERPLAY & IN VIVO PHAGE DISPLAY Complete
2006 R44 RFA-CA-06-005 LU, PETER S. ARBOR VITA CORPORATION A NOVEL DIAGNOSTIC ASSAY FOR ONCOGENIC HUMAN PAPILLOMAVIRUSES Complete
2009 R21 RFA-CA-08-009 SIMBERG, DIMITRI UNIVERSITY OF CALIFORNIA SAN DIEGO ISOLATION OF RARE CIRCULATING TUMOR CELLS FROM BLOOD USING MICROBUBBLES Complete
2013 R21 RFA-CA-13-001 WANG, ZHENGHE CASE WESTERN RESERVE UNIVERSITY NEXT-GENERATION MOUSE GENE-TARGETING TECHNOLOGY TO MODEL TUMORIGENESIS Complete
2016 R43 PAR-13-327 OUELLETTE, STEVEN BRADLEY KINASENSE, LLC DEVELOPMENT OF AN ASSAY PLATFORM FOR MEASURING ENDOGENOUS KINASE ACTIVITY Complete
2020 R44 PAR-18-303 FRIEDA, KIRSTEN SPATIAL GENOMICS, INC. Spatial and single cell analysis of tumor microenvironment by seqFISH+ Complete
2000 R33 PAR-99-100 WIGLER, MICHAEL H COLD SPRING HARBOR LABORATORY HIGH DENSITY GENE COPY NUMBER MICROARRAYS Complete
2002 R43 PAR-99-101 SHEFER, RUTH E NEWTON SCIENTIFIC, INC. A LASER-ACTIVATED REACTOR FOR BIOMEDICAL C-14-AMS Complete
2006 R21 RFA-CA-06-002 ZHANG, JIN JOHNS HOPKINS UNIVERSITY FLUORESCENT ACTIVITY SENSORS IN ANALYSIS OF ONCOGENIC P13K/AKT SIGNALING Complete
2008 R44 RFA-CA-06-006 BROWN, DAVID M AMBION DIAGNOSTICS, INC. MIRNA PROFILING IN FIXED CANCER SAMPLES Complete
2012 R21 RFA-CA-12-002 WANG, TZA-HUEI JOHNS HOPKINS UNIVERSITY PCR-FREE MULTIPLEXED DETECTION OF CIRCULATING MIRNA IN BLOOD Complete
2015 R43 PAR-13-327 EASTBURN, DENNIS J MISSION BIO, INC. MOLECULAR CHARACTERIZATION OF CIRCULATING TUMOR CELLS WITH PCR-ACTIVATED CELL SORTING Complete
2019 R21 RFA-CA-18-002 KEUNG, ALBERT NORTH CAROLINA STATE UNIVERSITY RALEIGH Intracellular CRISPR gRNA assembly for massively multiplexed; one pot; (epi)genetic screening Complete
2000 R21 PAR-99-100 HUNTER, IAN W MASSACHUSETTS INSTITUTE OF TECHNOLOGY ANDROGEN RECEPTOR BIOCHIPS--PROSTATE CANCER MANAGEMENT Complete
2002 R21 PAR-99-100 MAYER, BRUCE J UNIVERSITY OF CONNECTICUT SCH OF MED/DNT PROFILING TUMOR CELLS BY SH2 DOMAIN BINDING PATTERN Complete
2005 R21 RFA-CA-05-003 TUNG, CHING-HSUAN MASSACHUSETTS GENERAL HOSPITAL IMAGING TUMOR ASSOCIATED FIBROBLAST ACTIVATION PROTEIN Complete
2008 R21 RFA-CA-07-035 MCCAWLEY, LISA JOY VANDERBILT UNIVERSITY PARALLEL CAPILLARY BIOREACTORS FOR LEUKOCYTE TRANSENDOTHELIAL MIGRATION ANALYSIS Complete
2011 R21 RFA-CA-10-005 PARKER, LAURIE L. PURDUE UNIVERSITY LABEL-FREE, REAL-TIME DETECTION OF KINASE ACTIVITY IN VITRO AND IN SINGLE CELLS U Complete
2015 R21 RFA-CA-14-003 SARAF, RAVI F UNIVERSITY OF NEBRASKA LINCOLN HIGH SPECIFICITY MICRORNA MICROARRAY ANALYSIS WITHOUT PCR FOR CANCER SCREENING AND RESEARCH Complete
2018 R33 RFA-CA-17-011 JIANG, NING UNIVERSITY OF TEXAS, AUSTIN An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer Complete
1999 R41 PAR-98-066 MACH, ROBERT H ANASAZI BIOMEDICAL RESEARCH, INC. SIGMA 1 RECEPTOR PROBES FOR IMAGING TUMOR PROLIFERATION Complete
2001 R41 PAR-99-101 SULK, ROBERTA A DELTANU, LLC ONE STEP H. PYLORI TEST--SCREENING AND INDIVIDUAL ASSAYS Complete
2004 R33 PAR-01-106 ZANGAR, RICHARD C BATTELLE PACIFIC NORTHWEST LABORATORIES PROTEOMIC IDENTIFICATION OF NAF BIOMARKERS Complete
2007 R33 RFA-CA-07-001 ROTHSTEIN, RODNEY J. COLUMBIA UNIVERSITY HEALTH SCIENCES USING SYNTHETIC DOSAGE LETHALITY TO SCREEN FOR NOVEL ANTI-TUMOR TARGETS Complete
2010 R21 RFA-CA-09-008 KASSIS, AMIN I HARVARD MEDICAL SCHOOL NOVEL BLOOD ASSAY FOR LUNG CANCER DETECTION Complete
2014 R21 RFA-CA-13-003 PETRITIS, KONSTANTINOS PHOENIX CHILDREN'S HOSPITAL PRESERVATION OF DRIED PLASMA SPOTS FOR DOWNSTREAM PROTEOMIC APPLICATIONS Complete
2017 R33 RFA-CA-16-002 WANG, YINGXIAO UNIVERSITY OF CALIFORNIA, SAN DIEGO Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells Complete
2001 R21 PAR-99-102 ALLBRITTON, NANCY L UNIVERSITY OF CALIFORNIA IRVINE PROFILING RAS ACTIVATED SIGNAL TRANSDUCTION PATHWAYS Complete

Pages